295 related articles for article (PubMed ID: 84470)
41. [Mycosis fungoides. A form of pleuropulmonary origin with cutaneous sclerodermiform manifestations. Treatment by application of nitrogen mustard].
Gueguen MH
Bull Soc Fr Dermatol Syphiligr; 1971; 78(6):617-8. PubMed ID: 5161189
[No Abstract] [Full Text] [Related]
42. Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Groth O; Hellbe L; Holst R; Knudsen EA; Roupe G; Schmidt H
Acta Derm Venereol; 1980; 60(6):542-4. PubMed ID: 6162347
[TBL] [Abstract][Full Text] [Related]
43. Normalized light reactions in mycosis fungoides patients after complete remission of skin lesions.
Volden G
Acta Derm Venereol; 1980; 60(2):161-63. PubMed ID: 6155026
[TBL] [Abstract][Full Text] [Related]
44. [Mycosis fungoides].
Volden G; Eeg Larsen T
Tidsskr Nor Laegeforen; 1977 Nov; 97(32):1671-5. PubMed ID: 594965
[No Abstract] [Full Text] [Related]
45. Topical mechlorethamine therapy for mycosis fungoides.
Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
[TBL] [Abstract][Full Text] [Related]
46. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Zackheim HS; Epstein EH
Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
[TBL] [Abstract][Full Text] [Related]
47. Topical nitrogen mustard induced carcinogenesis.
Kravitz PH; McDonald CJ
Acta Derm Venereol; 1978; 58(5):421-5. PubMed ID: 82352
[TBL] [Abstract][Full Text] [Related]
48. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
Thestrup-Pedersen K; Christiansen JV; Zachariae H
Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
[TBL] [Abstract][Full Text] [Related]
49. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
[TBL] [Abstract][Full Text] [Related]
50. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
51. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
Monk BE; Vollum DI; du Vivier AW
Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
[No Abstract] [Full Text] [Related]
52. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E; Venetz JP; Aubert JD; Duchosal MA; Panizzon RG; Pascual M
Dermatology; 2008; 217(1):87-8. PubMed ID: 18446031
[TBL] [Abstract][Full Text] [Related]
53. Mycosis fungoides, nitrogen mustard and skin cancer.
Du Vivier A; Vonderheid EC; Van Scott EJ; Urbach F
Br J Dermatol; 1978 Jul; 99(1):61-3. PubMed ID: 678466
[TBL] [Abstract][Full Text] [Related]
54. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
55. [Total cutaneous electron beam therapy of mycosis fungoides].
Le Bourgeois JP; Levy E; Haddad E; Marinello G; Geara F; Pavlovitch JM
Ann Dermatol Venereol; 1989; 116(3):213-7. PubMed ID: 2662874
[TBL] [Abstract][Full Text] [Related]
56. Treatment of mycosis fungoides with topical BCNU.
Zackheim HS; Epstein EH; Grekin DA
Cancer Treat Rep; 1979 Apr; 63(4):623. PubMed ID: 156070
[No Abstract] [Full Text] [Related]
57. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
Zachariae H; Thestrup-Pedersen K
Acta Derm Venereol; 1987; 67(5):433-7. PubMed ID: 2448996
[TBL] [Abstract][Full Text] [Related]
58. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
59. Retinoid dermatitis mimicking progression in mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Group.
Molin L; Thomsen K; Volden G; Lange Wantzin G
Acta Derm Venereol; 1985; 65(1):69-71. PubMed ID: 2578710
[TBL] [Abstract][Full Text] [Related]
60. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
Price NM
Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
